Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

With regard to respiratory tuberculosis-related deaths from 1999 to 2020, common populations included older adults, males and ...

Seed oils, though often found in unhealthy foods, serve an important role in a healthy diet by functioning as a “key source” ...

The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...

Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.Approval of oral semaglutide ...

Many patients with advanced cancer who prefer treatment that prioritizes quality of life receive therapies focused on preserving it.A retrospective analysis showed nearly 40% of individuals with ...

Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...

Drugs commonly used in cancer immunotherapy carry the risk for ocular adverse events, according to a speaker.In a ...